| Autor: |
Strohbehn, Garth W., Kacew, Alec J., Goldstein, Daniel A., Feldman, Robin C., Ratain, Mark J. |
| Zdroj: |
Nature Biotechnology; Dec2021, Vol. 39 Issue 12, p1504-1510, 7p |
| Abstrakt: |
As pharmaceutical companies seek patent protection for combinations of cancer therapeutics, it is worthwhile to assess what constitutes an 'unexpected result' for the purpose of an appropriate patent and whether randomized, controlled trials of drug combinations have the ability to generate them. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink